AT | EUR
AT | EUR
Es konnten keine Ergebnisse gefunden werden.
At the Forefront in Fighting Cancer
Beyond Science
This August, the US Food and Drug Administration (FDA) approved a new kind of drug which could well represent a breakthrough in cancer treatment. This medicine called Kymriah, a combination of immune and gene therapies, is destined for the treatment of pediatric acute lymphoblastic leukemia. The results so far have been impressive.